Merit Medical Launches Super Hero and Hero Ally Dialysis Access Products

 

October 18, 2016—Merit Medical Systems, Inc. announced the launch of its Super Hero and Hero Ally dialysis access products, which will be introduced in the United States during the next 30 days. The devices will be scheduled for release in Europe after receipt of CE Mark approval.

According to the company, the Super Hero and Hero Ally devices are designed to assist in preserving existing fistulas or grafts that are in the process of failing because of central venous stenosis. These devices expand upon the company's Hero graft, providing an option of early cannulation grafts to bypass central venous stenosis. Merit Medical announced the purchase of the Hero graft device and related assets from CryoLife, Inc. in February 2016.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.